ディオスピロスカキの葉のポリフェノール抽出物は,抗グリケティブ剤の新しい食用源として:生物学的アクセシビリティと構造-活性関係の調査

Giulia Moretto1, Raffaella Colombo2, Sara Perteghella2

  • 1Drug Sciences Department, University of Pavia, 27100 Pavia, Italy; National Biodiversity Future Center (NBFC), 90133 Palermo, Italy.

まとめ

ディオスピロスカキの葉の抽出物は,有害な化合物を捕獲し,高度なグリケーション末端製品 (AGEs) を阻害することによって,抗グリケーションおよび抗老化の可能性を示しています. しかし,生物学的アクセシビリティが低いため,食品サプリメントとして効果的に使用するには,キャリアが必要になります.

関連する概念動画

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
615
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
230